About 90% of the company's research and development is done in “collaboration” with Claude, which Anthropic said means the model can do “large chunks of work under close human direction.” ...

Warnings from researchers about the technology's potential threats to humanity have sparked a debate among industry leaders ...

Cohere Inc. chief executive Aidan Gomez is criticizing calls from top leaders in artificial intelligence to slow the pace of ...

The researcher warned that AI leaders sincerely believe the technology could kill all of humanity by the decade’s end, saying it’s not a ’marketing stunt.’ ...

Apparently, folding is only Apple's warm-up stretch. Yesterday, Apple secured US patent 12,730,478 B2 detailing a stretchable ...

U.S. Attorney General Todd Blanche said the Department of Justice will investigate criminal activity involving the misuse of ...

By Yves Herman and Foo Yun Chee STRASBOURG, Sept 16 (Reuters) - European Commission President Ursula von der Leyen on ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...